Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Alpha-9 Oncology Raises $175M to Advance Radiopharmaceutical Pipeline
Details : The proceeds will advance the pipeline of targeted radiopharmaceuticals through clinical studies across multiple tumors and discovery stage assets to clinic-ready development candidates.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 23, 2024